文献速递产科母胎医学

无胎心胎囊征象对早期胚胎停育诊断的预测价值

Predictive value of presence of amniotic sac without visible embryonic heartbeat in diagnosis of early embryonic demise.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该前瞻性队列研究纳入6012例早期妊娠并发症孕妇,评估超声见胎囊但无活胚胎(胎囊征象)的诊断价值。在1135例活力不确定妊娠中,174例(15.3%)出现该征象,其中134例随访均确诊胚胎停育,特异度和阳性预测值均为100%。采用该征象可使活力不确定妊娠的随访扫描减少14.4%,占全部随访扫描的11%。

要点

  • 胎囊征象诊断早期胚胎停育特异度100%(95%CI 98.53-100.00%)。
  • 胎囊征象阳性预测值100%(95%CI 97.2-100.0%)。
  • 采用该征象可减少11%的全部随访扫描。

核心结论

  • 超声见胎囊但无活胚胎是早期妊娠失败的可靠标志,可减少诊断不确定时的随访扫描次数。

研究设计与样本

  • 前瞻性队列研究,纳入2017年7月至2018年11月单中心早期妊娠单元6012例孕<14周、有腹痛和/或出血症状或异位妊娠/流产史的孕妇。

主要发现

  • 6012例中4221例(70.2%)初次扫描确诊,1135例(18.9%)为活力不确定妊娠,656例(10.9%)为部位不明妊娠。
  • 活力不确定妊娠中174/1135例(15.3%)初次超声见胎囊但无活胚胎,其中134例随访均确诊胚胎停育。
  • 胎囊征象诊断早期妊娠失败的特异度100%(95%CI 98.53-100.00%),阳性预测值100%(95%CI 97.2-100.0%)。
  • 1403/6012例(23.3%)需随访扫描,其中活力不确定妊娠占1135/1403例(80.9%),部位不明妊娠占268/656例(40.9%)。
  • 采用胎囊征象可使活力不确定妊娠的随访扫描减少14.4%,占全部随访扫描的11%。

关键数值与推荐

  • 胎囊征象定义为正常位置宫内妊娠见胎囊但无活胚胎。
  • 该征象诊断早期妊娠失败特异度100%(95%CI 98.53-100.00%),阳性预测值100%(95%CI 97.2-100.0%)。

临床怎么用

  • 对于活力不确定妊娠,初次超声发现胎囊征象可考虑诊断胚胎停育,减少不必要的随访扫描。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the diagnostic value and impact on management of visualizing on ultrasound an amniotic sac without a live embryo (amniotic sac sign). We also examined the potential effect on the number of follow-up visits in early pregnancy units of incorporating this sign into current diagnostic algorithms. METHODS: This was a prospective cohort study of all pregnant women who attended a single specialist early pregnancy unit from July 2017 to November 2018 with symptoms of pain and/or bleeding, or with a history of ectopic pregnancy or miscarriage, at < 14 weeks' gestation. Detailed initial ultrasound findings were documented, including whether an amniotic sac was present in a normally sited intrauterine pregnancy with absence of a live embryo. Women were followed up until a conclusive diagnosis was made. RESULTS: The study included 6012 women who attended our unit with early pregnancy complications during the study period. A conclusive diagnosis was reached on the initial scan in 4221 (70.2%), whilst 1135 (18.9%) women had a pregnancy of uncertain viability and 656 (10.9%) had a pregnancy of unknown location (PUL). All women with a pregnancy of uncertain viability required follow-up ultrasound scans to differentiate between a live pregnancy and early embryonic demise. An amniotic sac in the absence of a live embryo was found in 174/1135 (15.3%) women with a pregnancy of uncertain viability at the initial ultrasound scan. The diagnosis of early embryonic demise was confirmed in all 134 of these women who attended their follow-up scans. The presence of an amniotic sac without a live embryo at the initial visit had a specificity of 100% (95% CI, 98.53-100.00%) and positive predictive value of 100% (95% CI, 97.2-100.0%) for the diagnosis of early pregnancy failure. A total of 1403/6012 (23.3%) women were asked to attend for a follow-up ultrasound scan to resolve diagnostic uncertainties, including 268/656 (40.9%) women with a PUL. The majority of follow-up scans needed to reach a conclusive diagnosis were in women with a pregnancy of uncertain viability (1135/1403 (80.9%)). By using the presence of the amniotic sac sign to diagnose early pregnancy failure at the first visit, the number of follow-up scans for pregnancies of uncertain viability would be reduced by 14.4%, which accounted for 11% of all follow-up scans during the study period. CONCLUSIONS: The finding on ultrasound of an amniotic sac without a live embryo (amniotic sac sign) is a reliable marker of early pregnancy failure and could reduce the number of follow-up scans by 11% in cases of diagnostic uncertainty. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dooley WM, De Braud L, Thanatsis N, et al. Predictive value of presence of amniotic sac without visible embryonic heartbeat in diagnosis of early embryonic demise. Ultrasound Obstet Gynecol. 2021. PMID: 33147646. doi:10.1002/uog.23533

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。